In this study, we investigated CD70 as a promising target for renal cell carcinoma (RCC) therapy and developed a potent chimeric antigen receptor T (CAR-T) cells for potential clinical testing. The gene discussed is CD70; the disease is hereditary clear cell renal cell carcinoma.